| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |